Human T-Lymphotropic Virus 1 (HTLV-1)-Associated Lichenoid Dermatitis Induced by CD8+ T Cells in HTLV-1 Carrier, HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis and Adult T-Cell Leukemia/Lymphoma

    June 2015 in “ The Journal of Dermatology
    Y. Tokura, Taisuke Ito, Chika Kawakami, Kazunari Sugita, Akira Kasuya, Kazuki Tatsuno, Yu Sawada, Motonobu Nakamura, Takatoshi Shimauchi
    TLDR HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.
    The study reviewed 50 patients with HTLV-1-associated diseases from 2002 to 2012, focusing on those with skin lesions showing lichenoid tissue reactions predominantly infiltrated by CD8+ T cells. These patients included HTLV-1 carriers, those with HAM/TSP, and those with smoldering ATLL. The skin conditions observed were erythroderma, lichen planus, alopecia areata, chronic actinic dermatitis, and discoid lupus erythematosus. The researchers coined the term HTLV-1-associated lichenoid dermatitis (HALD) to describe these conditions, suggesting that HALD may be linked to elevated immunity against HTLV-1-infected CD4+ T cells, similar to the immune response seen in HAM/TSP.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results

    Related

    1 / 1 results